# Carisma Announces Delisting from Nasdaq and SEC Deregistration
Canonical URL: https://biopharmsignal.com/news/CARM/carisma-announces-delisting-from-nasdaq-and-sec-deregistration
Ticker: CARM
Company: Carisma Therapeutics, Inc.
Source: Carisma Therapeutics, Inc.
Published: 2025-12-05 16:16 EST
Original Source URL: https://ir.carismatx.com
## Summary

PHILADELPHIA , Dec. 5, 2025 /PRNewswire/ -- Carisma Therapeutics Inc. (OTCID: CARM) (the "Company") today announced that its Board of Directors (the "Board") has approved and the Company intends to proceed with the voluntary delisting of its common stock from The Nasdaq Stock Market LLC ("Nasdaq")

## Article Body
PHILADELPHIA , Dec. 5, 2025 /PRNewswire/ -- Carisma Therapeutics Inc. (OTCID: CARM) (the "Company") today announced that its Board of Directors (the "Board") has approved and the Company intends to proceed with the voluntary delisting of its common stock from The Nasdaq Stock Market LLC ("Nasdaq")
## Recent Company News
- 2025-12-05 16:16 EST — [Carisma Announces Delisting from Nasdaq and SEC Deregistration](https://biopharmsignal.com/news/CARM/carisma-announces-delisting-from-nasdaq-and-sec-deregistration) — Source: Carisma Therapeutics, Inc.
- 2025-03-31 20:30 EST — [Carisma Therapeutics Provides Corporate Updates](https://biopharmsignal.com/news/CARM/carisma-therapeutics-provides-corporate-updates) — Source: Carisma Therapeutics, Inc.
- 2025-02-19 12:30 EST — [Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference](https://biopharmsignal.com/news/CARM/carisma-therapeutics-to-participate-in-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference) — Source: Carisma Therapeutics, Inc.
- 2025-02-05 12:30 EST — [Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference](https://biopharmsignal.com/news/CARM/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference) — Source: Carisma Therapeutics, Inc.
- 2024-12-09 13:30 EST — [Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline](https://biopharmsignal.com/news/CARM/carisma-therapeutics-announces-strategic-restructuring-to-re-prioritize-pipeline) — Source: Carisma Therapeutics, Inc.
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)